Wikipedia -WSS

Wikipedia

author：focus 2025-10-02 13:14:33 - browse：8571

As a new class of diabetes and obesity medications has soared in popularity, so have the online outlets built to get them in the hands of patients. A new analysis of claims data from Trilliant Health suggests that collectively, telehealth companies — in particular, cash-pay options that market directly to consumers — could account for many of the patients with insurance claims for GLP-1 prescriptions in 2022.

Direct-to-consumer telehealth companies have offered an easier on-ramp for many patients to access prescriptions for a variety of conditions. And since the first GLP-1s were approved for obesity — promising up to 15% weight loss — many of those companies have capitalized on the approvals and surging demand to launch new weight loss businesses. Companies including Calibrate and Ro claim to have reached tens and hundreds of thousands of patients with their weight loss medication programs.

Collectively, their reach may be even larger. The Trilliant Health analysis, conducted on behalf of STAT, offers an early glimpse of the foothold those businesses have gained in GLP-1 prescribing. In a nationwide claims database of more than 300 million patients using both commercial and federal insurance, Trilliant Health found about 3.6 million people with a prescription claim for a GLP-1 — semaglutide, tirzepatide, or injectable liraglutide without insulin — in 2022. To determine where each patient may have gotten those prescriptions, they looked for a medical visit claim within three days of a prescription claim for a GLP-1 — the visit where the script was likely written. But they only found a matching visit for 53% of patients.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Manchin plays down potential 3rd

entertainment

WSS

Health AI: on the border between health care and tech

Montana youths win climate lawsuit against state for promoting fossil fuels

Study: Hearing aids may slow cognitive decline in those at risk

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

Manchin plays down potential 3rd

leisure time

Wikipedia

leisure time

As demand for Covid shots wanes, Moderna seeks its next success

A look at other Americans who have crossed into North Korea over the years

Cancer drug shortages should be causing more outrage

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Novavax promises a turnaround & Lilly roils the obesity market

Flagship, Pfizer team up in deal worth up to $7 billion

Psychedelics group wrestles with new pharma identity

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Jerome Adams on the need for new antivirals for Covid

Flagship, Pfizer team up in deal worth up to $7 billion

hotspot

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

YouTube cracks down on misinformation on cancer treatment

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Study: Hearing aids may slow cognitive decline in those at risk

Megan Rapinoe shares emotional post following US Women's World Cup exit

knowledge

entertainment

entertainment

focus